PrecISE Severe Asthma Interventions

Trial Objective

PrecISE Severe Asthma InterventionsThe purpose of this study is to understand how to treat different types of severe asthma using precision medicine. Precision medicine is an approach that targets treatments to defined subgroups of patients who share similar characteristics. For example, patients who have a certain genetic variation or patients with high number of blood eosinophils. Study participants will receive several treatments based on their type of severe asthma for research purposes.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Individuals 12 years of age and older whose asthma symptoms are not well-controlled on high dose of inhaled corticosteroids, including those who have frequent asthma attacks.

Age: 12+    Gender: Any Gender


Estimated Time Commitment

3 phases, approximately 9 visits per phase for up to 2 years



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Nick Bonfiglio

Nick Bonfiglio
303.398.1443

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institutes of Health

Principal Investigators

Co-Investigators


Request More Information

After limiting clinical research activity due to safety concerns about COVID-19, we are now restarting clinical research in stages. If you are interested in any of the clinical trials posted on our website, please request trial information. We will respond and share the timing for enrollment resuming. Learn More


*
*
*
*